CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
Columbus, Ohio, United States and 45 other locations
care (prenatal visits, self-monitored blood glucose, and certified diabetes care and education specialist) on achieving glycemic control (he...
Columbus, Ohio, United States
This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...
Phase 3
Columbus, Ohio, United States and 78 other locations
the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...
Columbus, Ohio, United States and 25 other locations
Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...
Phase 3
Columbus, Ohio, United States and 75 other locations
allograft, and/or Amnion/Amnion allograft, plus Standard of Care (SOC) each versus SOC alone in the treatment of chronic non-healing diabetic...
Circleville, Ohio, United States and 8 other locations
This study is comparing the medicine RYBELSUS® to other medicines in people with type 2 diabetes who need extra treatment. All medicines use...
Phase 4
Columbus, Ohio, United States and 22 other locations
and how safely bimagrumab, tirzepatide, and the combination, work in lowering body weight in participants with obesity or overweight and type 2 diabetes...
Phase 2
Columbus, Ohio, United States of America and 36 other locations
The main purpose of this study is to determine safety and efficacy of orforglipron compared with placebo in adult participants with type 2 diabetes...
Phase 3
Dublin, Ohio, United States and 91 other locations
The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes...
Phase 3
Columbus, Ohio, United States of America and 133 other locations
Clinical trials
Research sites
Resources
Legal